Sports: Price moratorium for medicines: pharmaceutical companies run storm against Lauterbach's plans

Fiona's trajectory, power and precipitation — illustrated in graphics

  Fiona's trajectory, power and precipitation — illustrated in graphics Hundreds of thousands of people in the Maritimes remained without power Sunday following post-tropical storm Fiona, which brought fierce gusts of wind, heavy rain and serious infrastructure damage across Atlantic Canada. After surging north from the Caribbean, Fiona came ashore before dawn Saturday as a post-tropical cyclone, battering Nova Scotia, Prince Edward Island, Newfoundland, New Brunswick and Quebec with hurricane-strength winds, heavy rains and huge waves.

 Foto: dpa Picture-Alliance © provided by Wirtschaftswoche Photo: dpa picture-alliance data portal copyright =

A law planned by the Minister of Health should ask the pharmaceutical manufacturers more. Karl Lauterbach wants to restrict it much more in pricing. They defend themselves - with good arguments.

The Germany bosses of the International Pharmaceuticals Novartis, Bristol-Myers Squibb and MSD, the daughter of the US group Merck & Co., unanimously demand that the law are not adopted and instead hold an innovation summit with the federal government.

With the "GKV Finance Stabilization Act", which is to be passed in the next few weeks, Lauterbach wants to compensate for the 17 billion euro deficit of the health insurance companies expected in 2023. Another price moratorium for medicines is planned by the end of 2026. The compulsory discount that manufacturers have to grant the cash registers is to be increased. Only six months after the introduction - instead of a year - manufacturers should be able to freely determine their prices. Price borders and discounts are also planned. Further austerity measures concern pharmacists and doctors.

Feds move from ‘response’ to ‘recovery’ following Fiona

  Feds move from ‘response’ to ‘recovery’ following Fiona There are approximately 100 personnel per province available to assist Nova Scotia, Prince Edward Island and Newfoundland and Labrador.“Time is of the essence and a speedy response is what’s required,” he said, during a press conference held by a number of federal ministers to provide an update on the storm.

Care endangers

"The law in this form must be stopped," says Neil Archer, head of Germany of the US group Bristol Myers Squibb. Archer holds large pieces in Germany. For example, the high number of well -qualified workers speak for the location. In contrast to neighboring countries such as Poland, Germany is also well supplied with innovative medication. “I would regret it if that changes. The new law can happen, ”says Archer.

The planned set is currently at risk of care for patients, says Chantal Friebertshäuser, head of MSD: “Schrid innovations that increase the survival time of patients are no longer rewarded when setting up. We have to ask ourselves whether we can bring innovative medication onto the market as before. ”In 2021, the pharmaceutical industry caused massive savings in the healthcare sector through legally required discounts and fixed amounts of 21 billion euros, said Friebertshäuser.

30 most expensive US classic cars ever

  30 most expensive US classic cars ever 30 most expensive US classic cars ever

poison for investments

Novartis would like to invest in a new location in Germany, said managing director Heinrich Moisa: "But if I suggest it internally, it quickly becomes clear that the planned law is poison." Moisa refers to the proportion of the proportion Pharmaceutical expenditure has remained constant in the past ten years. The new law now provides for another price moratorium for the next few years: "We are the only industry that may not pass on the higher costs by inflation by law." Although the pharmaceutical industry should shoulder the main burden on the new law, Overall, just for twelve percent of the statutory health insurance expenses.

criticism also comes from German manufacturers, for example from Boehringer Ingelheim. Due to the planned higher compulsory discount alone, Boehringer loses another forty million euros in 2023, according to the company. In addition to the manufacturers,

Fiona reshaped P.E.I.'s coastlines, stoking fears for the Island's future

  Fiona reshaped P.E.I.'s coastlines, stoking fears for the Island's future A picture of how much post-tropical storm Fiona has reshaped Prince Edward Island is beginning to emerge — and in some cases, whole coastlines made of sand and stone have been erased. The storm hit P.E.I. in the early morning hours of Sept. 24, leaving widespread destruction. Six days after Fiona, the cleanup is far from over, with the majority of the Island still without power, and downed trees and power lines still blocking driveways and roads. As Islanders begin the long road to recovery, many are wondering where to rebuild and how far from the shore is safe enough.

also criticize medical societies the planned law. They fear that this could make it difficult to access chronically ill people to new drugs.

also read: Germany's dependence on foreign pharmaceutical abrasions becomes the risk of

readers' favorites: High inflation: Should savers cover more money now - or less?

10 percent inflation: "In the end only the hard cut"

attacks on the North Stream pipelines: only two submarines? Really now?

residential real estate: 2022 ends with a real estate boom, no bladder flock

Spain as a pioneer: gas price lid: Is the "Iberian solution" a model for Germany?

medical practices open later: Protest against Lauterbach plans .
To protest against planned performance cuts, open numerous medical practices in Bavaria two hours later: 10 a.m. instead of 8:00 a.m. The Association of Statutory Health Insurance Physicians and the medical and psychotherapeutic professional associations of Bavaria have called on their members for this step. According to the professional association for pediatricians, many pediatricians will also temporarily close their practices.

See also